✓
No active regulatory warnings
Sources: FDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
1 Identity
D-Ribose
D-Ribose
Generally SafeEvidence: LimitedOtherD-Ribose is a pentose sugar that is a structural component of ATP (adenosine TRI-phosphate), RNA, and NADH. It accelerates ATP resynthesis in ischemic or energy-depleted tissues (heart, skeletal muscle) [1]. Some evidence supports use in heart failure (improved diastolic function) and fibromyalgia/CFS (improved energy), though trials are small [2]. It is marketed as an 'energy supplement' but works through ATP synthesis, not stimulation [1].
2 Risk self-assessment
Not applicable — not an essential nutrient [1]
Select factors above to see your risk level
4 Dietary sources
Endogenously synthesized. Not a significant food component [1].
5 Lab interpreter
Blood glucose
Your level:
Enter a value above
⚕ For healthcare professionals. Does not replace clinical judgment.
6 Quick facts
CategoryOther
Safety levelGenerally Safe
EvidenceLimited
RDATypical 5–15 g
Upper limit (UL)No UL
Scientific nameD-Ribose
Chemical classPentose sugar (5-carbon monosaccharide) [1]
ATP roleStructural component of ATP, RNA, NADH, FADH2 [1]
MechanismAccelerates ATP resynthesis in ischemic/depleted tissue [1]
Heart failureSmall trials: improved diastolic function [2]
CFS/fibromyalgiaSmall pilot positive for energy/well-being [2]
Typical dose5–15 g/day in divided doses [2]
7 Dosage by population
Adults Moderate
See product label
Elderly Moderate
See product label
Consider reduced renal/hepatic clearance. Start at lower end of range.
Athletes Limited
Standard dose
Obesity Limited
Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
Renal Limited
Consult specialist
Dose adjustment may be needed in renal impairment.
Vegan Moderate
Standard dose
8 Form comparison
| Form | Bioavailability | Vegan | Cost/day |
|---|---|---|---|
| ['D-Ribose powder', 'common', 'Sweet taste. 5 g per tsp. 5–15 g/day divided [1].'] | Standard | Check label |
9 Clinical evidence
Strong evidence
ATP structural component: basic biochemistry [1]. Accelerates ATP resynthesis post-ischemia: confirmed in animal and cell models [1]. HIGH
Moderate evidence
Heart failure: small trials showed improved diastolic function and exercise tolerance [2]. CFS/fibromyalgia: one pilot (n=41) — 66% reported significant improvement in energy and well-being [2]. MODERATE
Insufficient evidence
10 Safety
🚩 Red flags — when to stop and refer
● Diabetic patient — hypoglycemia risk [1]
Pregnancy
No data [1].
Pediatric
No data [1].
11 Toxicity and overdose
12 Drug interactions
13 Supplement interactions
Best combined with
CoQ10 + L-Carnitine · 100–200 mg CoQ10 + 500–1,000 mg carnitine
Mitochondrial energy triad: ribose (ATP backbone) + CoQ10 (electron transport) + carnitine (fatty acid transport) [1].
Mitochondrial energy triad: ribose (ATP backbone) + CoQ10 (electron transport) + carnitine (fatty acid transport) [1].
14 Laboratory monitoring
Blood glucose Primary
Target: Monitor for hypoglycemia · If diabetic [1].
D-ribose may lower glucose [1].
15 Deficiency and prevalence
Risk factors
• Not applicable — not an essential nutrient [1]
16 Frequently asked questions
Does D-ribose give energy like caffeine? ▼
No — completely different mechanism. Caffeine blocks adenosine (stimulant). D-ribose provides the sugar backbone for ATP resynthesis (metabolic). No stimulatory 'buzz' — it supports cellular energy production [1].
Can D-ribose lower blood sugar? ▼
Yes — it has been reported to cause hypoglycemia in some individuals. Monitor glucose, especially in diabetics [1].
17 Regulatory status
United States: GRAS. Dietary supplement [1].
18 References
[1]Shecterle LM, et al. The patented uses of D-ribose in cardiovascular diseases. Recent Pat Cardiovasc Drug Discov. 2010;5(2):138-142. doi:10.2174/157489010791515241 REVIEW
[2]Teitelbaum JE, et al. The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. J Altern Complement Med. 2006;12(9):857-862. doi:10.1089/acm.2006.12.857 REVIEW
19 Related articles
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
Auto-updated from GMJ Newsroom. Articles tagged "D-Ribose" appear here.
20 Cite this page
Vancouver
Pkhakadze G. D-Ribose — safety profile [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 May 30]. Available from: https://supplement.ge/ingredients/d-ribose/
APA 7th
Pkhakadze, G. (2026). D-Ribose — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/d-ribose/
CC BY 4.0
🛡 SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
GP
Reviewed by Prof. G. Pkhakadze, MD, MPH, PhD
Editor-in-Chief, Georgian Medical Journal · Chair, PHIG
Last reviewed: May 2026 · Next: November 2026
This entry is provided for educational and public health purposes under CC BY 4.0. Consult your healthcare provider before starting any supplement. For corrections: info@accreditation.ge.
Publisher: PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Publisher: PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD